📦 Unpacked #15: Intuitive Surgical
Our Full Deep Dive & Fundamental Score of Intuitive Surgical ⭐
Welcome to the 15th edition of Unpacked, our monthly series where we take a deep dive into a company. This time, we’re taking a closer look at Intuitive Surgical — the global leader in robotic-assisted surgery, transforming surgery through advanced robotic systems, software, and data-driven innovation.
We break down its story, business model, and highlight the latest developments.
Additionally, we do a detailed fundamental analysis, diving into the company’s management, market, financials, and growth estimates. We score each area separately, leading to a final score between 0 and 100. This score reflects how fundamentally attractive we believe the company is as an investment, ranging from:
🔴 Below 50 → Uninvestable
🟠 50 - 59 → Questionable
🟡 60 - 69 → Reasonable
🟢 70 - 79 → Quality
🔵 80 - 89 → High-Quality
🟣 90 or above → Exceptional
The goal? To give you a full deep dive into this company, as a complement to your own research, so you can decide if it’s the right investment for you.
In case you missed it, here you can read the previous editions of Unpacked:
Now let’s unpack the fundamentals of Intuitive Surgical and see how we score it!
History and Business Model
Intuitive Surgical was founded in 1995 by Frederic Moll, John Freund, and Robert Younge, with the idea of using robotics to make surgery less invasive and more precise.
The technology behind the company came from early research into robotic surgery. Intuitive saw the opportunity to turn this technology into a system that could be used in hospitals around the world. This led to the creation of the da Vinci Surgical System.
The first da Vinci system was launched in Europe in 1999, followed by FDA clearance in the United States in 2000. That same year, Intuitive Surgical went public on the Nasdaq under the ticker ISRG.
One of the first important uses for da Vinci was urology, especially prostate surgery. As more surgeons and hospitals started using the system, Intuitive expanded into other areas of surgery and improved its technology.
In 2006, the company launched its second-generation da Vinci S, followed by the third-generation da Vinci Si. From 2014, Intuitive introduced its fourth-generation systems, including da Vinci X, Xi, and SP. Each new generation made the technology better and allowed surgeons to use da Vinci for a wider range of procedures.
Intuitive later expanded beyond traditional surgery. In 2019, it launched Ion in the United States, a robotic-assisted bronchoscopy platform that helps physicians reach and biopsy small nodules deep inside the lungs, with the goal of helping detect lung cancer earlier.
The latest major step came with da Vinci 5, launched in the United States in 2024 and Europe in 2025. Intuitive’s fifth-generation platform offers better ergonomics and more than 10,000x the computing power of da Vinci Xi, creating a new foundation for the future of robotic-assisted surgery.
Source: Intuitive Surgical, company history and product information
Over the past three decades, Intuitive has grown from a pioneer in robotic surgery into the global leader in robotic-assisted minimally invasive care, with its technology now used by hospitals and surgeons around the world.
Its mission is:
“We believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.”
Business Model Explained
Intuitive Surgical has built an ecosystem around robotic-assisted minimally invasive care. Its technology helps physicians perform procedures with more precision and control, often using smaller incisions than traditional open surgery.
At the center of this ecosystem are two robotic platforms:
🤖 1. da Vinci
Da Vinci is Intuitive’s core platform and is used for robotic-assisted surgery. Surgeons control the system from a console and use robotic instruments to make precise movements while seeing the surgical area in a detailed 3D view. Da Vinci is used in areas such as urology, gynecology, general surgery, and thoracic surgery.
🫁 2. Ion
Ion expands Intuitive beyond surgery into robotic-assisted bronchoscopy. It helps physicians navigate deep into the lungs and take tissue samples from small nodules that can be difficult to reach. These samples can then be tested for diseases such as lung cancer.
Around da Vinci and Ion, Intuitive has built a broader ecosystem of instruments, accessories, training, services, and digital solutions. Tools such as My Intuitive, Intuitive Hub, and SimNow help surgeons and hospitals with training, procedure data, and insights.
How Intuitive Surgical Makes Money 💰
Intuitive earns its revenue from:
🩺 Instruments and accessories used during procedures
🤖 Sales and leases of da Vinci and Ion systems
🔧 Service and support for installed systems
What makes the business model attractive is that selling a system is only the beginning. Each installed system can generate recurring revenue for years as more procedures are performed and hospitals keep buying instruments, accessories, and services.
This creates a powerful cycle: more systems → more procedures → more recurring revenue.
Revenue Breakdown
On July 16, 2026, Intuitive Surgical reported its second quarter 2026 results. Total revenue reached $2.89 billion (+19% YoY), supported by higher procedure volumes, system leasing revenue, and a larger installed base of da Vinci and Ion systems.
🩺 Instruments & Accessories – $1.73 billion (60%)
Intuitive’s largest source of revenue. These are the instruments and accessories used during da Vinci and Ion procedures. Revenue increased 18% YoY, with da Vinci procedures growing 15% and Ion procedures 36%.
🤖 Systems – $685 million (24%)
Revenue from da Vinci and Ion systems. Intuitive placed 468 da Vinci systems during the quarter, including 246 da Vinci 5 systems, as well as 55 Ion systems.
🔧 Services – $472 million (16%)
Revenue from service and support for Intuitive’s growing installed base of systems.
The revenue mix shows the strength of Intuitive's business model: around 76% of Q2 revenue came from instruments, accessories, and services, giving Intuitive a large recurring revenue base that grows as its installed base and procedure volumes increase.
Recent Developments
Intuitive Surgical is entering a new phase. The company has new leadership, is bringing da Vinci 5 to more markets, expanding into more procedures, and investing more in software, AI, and digital technology.
Here are the key developments:
1️⃣ Dave Rosa Becomes CEO
In July 2025, Dave Rosa became CEO of Intuitive Surgical, replacing Gary Guthart after 15 years as CEO. Guthart remained with the company as Executive Chairman.
Rosa had already served as President since 2023 and has been with Intuitive since 1996. Before becoming CEO, he oversaw areas including product, digital, manufacturing, and commercial operations.
2️⃣ Da Vinci 5 Expands Globally
After launching in the U.S. in 2024, Intuitive started bringing da Vinci 5 to more international markets. The system received regulatory clearance in Japan in June 2025 and CE marking in Europe in July 2025.
Da Vinci 5 is Intuitive’s most advanced system, with more than 150 improvements and over 10,000x the computing power of da Vinci Xi.
Source: Intuitive Surgical – Da Vinci 5 product page
3️⃣ More Procedures Added to da Vinci
Intuitive continues to expand what surgeons can do with its systems. During 2025, da Vinci SP received new FDA clearances for areas including colorectal surgery, hernia repair, gallbladder removal, and appendectomy. In January 2026, da Vinci 5 was also cleared for cardiac procedures, opening another important area for the platform.
4️⃣ AI & Telesurgery
AI is becoming a bigger part of Intuitive’s strategy. In July 2026, the company introduced a five-layer AI framework, moving from surgical data and insights toward real-time guidance, augmented dexterity, and eventually supervised autonomy. The strategy builds on data from more than 20 million da Vinci procedures.
Intuitive is also advancing telesurgery. After demonstrating transatlantic telesurgery in 2025, the company conducted another live demonstration in July 2026 using da Vinci 5, Force Feedback, and shared control between surgeons in California and Georgia. The technology is still in development and not yet commercially available.
Source: Intuitive Surgical – Vision for an AI-Enabled Future of Healthcare
5️⃣ Expanding Directly in Europe
In March 2026, Intuitive completed acquisitions of several European distribution businesses, expanding its direct presence in Italy, Spain, Portugal, Malta, and San Marino. This allows Intuitive to work more directly with hospitals and surgeons in these markets instead of relying on distributors.
6️⃣ Building a Larger Intuitive Ecosystem
Intuitive continues to expand beyond its robotic systems. In May 2026, the company announced new da Vinci 5 features, telecollaboration capabilities, Force Feedback instruments, and other improvements. The company is building a broader ecosystem around robotics, instruments, software, data, training, and AI, making its platforms more useful over time.
🔥 Upgrade Now and Save 30%!
Get instant access to this Intuitive Surgical Full Deep Dive, all other Deep Dives, our Portfolios & Transactions, our monthly Best Buys, 95+ Stock Battles — plus 400+ premium articles!
✅ Already trusted by 4,800+ investors.
Fundamental Analysis
Now it’s time for the fundamental analysis of Intuitive Surgical.
In this section, we evaluate three key areas: management, market, and financials & growth estimates. Each area contains multiple elements and each element is scored individually, leading to a final score between 0 and 100.
Final Scoring
This score reflects how fundamentally attractive we believe Intuitive Surgical is as an investment, ranging from:
🔴 Below 50 → Uninvestable
🟠 50 - 59 → Questionable
🟡 60 - 69 → Reasonable
🟢 70 - 79 → Quality
🔵 80 - 89 → High-Quality
🟣 90 or above → Exceptional
Unlock our scoring framework and full fundamental analysis below, and see how we score Intuitive Surgical on a scale from 0 to 100 — exclusively available to our paid members! ✨
First, let’s walk through our scoring framework 📊👇